TME

Feb 21 2025HEALTH

Brain Drain: How Doctors Feel Appreciated in the Neurology World

In the world of medicine, especially in neurology, it's crucial to understand how doctors and trainees feel about their work environment. A recent study focused on this, looking at how different ways of showing appreciation are seen by faculty and trainees in a neurology department at a big academic

reading time less than a minute
Feb 21 2025HEALTH

Unlocking Lung Cancer Secrets: KRAS Mutations and Treatment

Lung cancer is a tricky disease, and one type, non-small cell lung cancer (NSCLC), can be even trickier. Why? Because it can have different mutations, and these mutations can affect how well treatments work. Two of these mutations are called KRAS G12C and KRAS G12D. They are not the same and can beh

reading time less than a minute
Feb 21 2025HEALTH

Migraines: A Hidden Epidemic

Migraines are a big deal, affecting around 14. 4% of people worldwide. This means nearly one in seven individuals is dealing with this painful condition. The goal was to understand who gets migraines and how it impacts their healthcare needs. First, let's talk about the numbers. Migraines are more

reading time less than a minute
Feb 20 2025FINANCE

Palantir: A Tech Titan on the Rise

Palantir, a software giant, is making waves in the artificial intelligence (AI) market. Loop Capital, a financial firm, has given it a thumbs-up with a buy rating and a price target of $141. This means they think the stock could jump by more than 25% from its current price. The firm believes Palanti

reading time less than a minute
Feb 20 2025SCIENCE

Gold Nanoparticles: A New Hope for Alzheimer's Treatment?

Alzheimer's disease is a tough opponent, but scientists are finding new ways to fight it. Gold nanoparticles, tiny particles made of gold, are proving to be a powerful tool in the battle against this neurodegenerative disease. These nanoparticles can be loaded with afzelin, a natural compound found

reading time less than a minute
Feb 20 2025HEALTH

Rituximab and COVID-19: A Real-World Test for Tixagevimab-Cilgavimab

People with rheumatic diseases often take rituximab, a medicine that can make them more likely to catch COVID-19. Doctors wanted to see if a new treatment, tixagevimab-cilgavimab, could help. This combo was tested on patients already taking rituximab. The goal was to find out if it could stop COVID-

reading time less than a minute
Feb 20 2025POLITICS

Trump's Speech at Saudi-Backed Event Raises Eyebrows

In February 2025, former President Donald Trump took the stage at the FII PRIORITY Summit in Miami Beach. This event, backed by Saudi government entities, was all about bringing together big names in business and politics. The main sponsor? The Saudi Public Investment Fund, with other Saudi governme

reading time less than a minute
Feb 20 2025HEALTH

Mental Health and Crime: Do Community Treatment Orders Make a Difference?

People with mental health issues have sometimes been linked to violent acts and other crimes. This has led to questions about how well community treatment orders (CTOs) work in managing these behaviors. CTOs are legal orders that require individuals to receive treatment in the community rather than

reading time less than a minute
Feb 20 2025POLITICS

Justice in the Crosshairs: Trump's Media Group Takes Aim at Brazilian Court

A media company linked to former President Donald Trump has taken a bold step by filing a lawsuit against a Brazilian Supreme Court justice. This move comes just hours after former Brazilian President Jair Bolsonaro, a close ally of Trump, faced indictment. The lawsuit, filed in a U. S. federal cour

reading time less than a minute
Feb 20 2025HEALTH

High Blood Pressure: The Silent Killer and Why Free Meds Matter

High blood pressure, or hypertension, is a serious issue worldwide. It's the leading cause of death globally, and sadly, most of these deaths happen in countries that are not wealthy. You might be surprised to learn that only a small fraction of people with this condition have it under control. In p

reading time less than a minute